Prostate cancer is the most common cancer in men over the age of 50 in Europe1. Hydrogel spacing for prostate cancer patients is a technique to temporarily create space between the prostate and rectum, designed to reduce the radiation dose delivered to the rectum during prostate cancer radiation therapy.
Research in this space is rapidly evolving, which is why we offer you recorded lectures and webinars from leading international experts discussing latest clinical evidence, procedural tips and tricks, different treatment modalities and patient outcomes.
Learn from Experts
Emerging Techniques
Emerging techniques in radiation oncology: the future of rectal spacing in prostate SBRT - the urologist and radiation oncologist perspective
Advancing Radiation Therapy with SBRT and Hydrogel Spacer
Prof. Filippo Alongi, Prof. Michael Zelefsky
SpaceOAR Vue™ Hydrogel
SpaceOAR Vue & Treatment Planning
Sean P. Collins, M.D., Ph.D.
Dr. Albert Edwards, Kent (England)
Experience in using SpaceOAR Vue™ Hydrogel
Prof. Michelle McNicholas
See things differently with Dr. Clive Peedell
Dr. Clive Peedell
Shorter workflow with a radiopaque hydrogel spacer?
Dr. Petereit
Procedure and Safety
SpaceOAR Vue™ Hydrogel. Assembly Step-By-Step Overview
Application Technique for SpaceOAR Vue™ Hydrogel
Dr. Asunció Hervas, Dr. José Dominguez
Advancing Prostate Health: Prostate Cancer Radiation Therapy and SpaceOAR Vue™ Implantation.
Prof. Dr. Preston Sprenkle moderated by Glyn Burtt
Quality of Life / Radiation Toxicity
See things differently with Prof. Dr. Michael Pinkawa
Dr. Michael Pinkawa
Prof. Heather Payne
Patient Stories
References
1. The web is: https://www.europa-uomo.org/why-we-are-needed/ [Accessed October 8, 2020]
Disclaimer
SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum. SpaceOAR and SpaceOAR Vue Hydrogels contain Polyethylene Glycol (PEG). SpaceOAR Vue Hydrogel contains iodine. Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection, pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels, local inflammatory reactions, infection (including abscess), urinary retention, urgency, constipation (acute, chronic, or secondary to outlet perforation), rectal tenesmus/muscle spasm, mucosal damage, ulcers, fistula, perforation (including prostate, bladder, urethra, rectum), necrosis, allergic reaction (localized or more severe reaction, such as anaphylaxis), embolism (venous or arterial embolism is possible and may present outside of the pelvis, potentially impacting vital organs or extremities), syncope and bleeding. The occurrence of one or more of these complications may require treatment or surgical intervention. URO- 989811-AB MAR 2022
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.
SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum. As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection; pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR and SpaceOAR Vue Hydrogels into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR and SpaceOAR Vue Hydrogels intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.